Page last updated: 2024-10-15

way 200070

Description

WAY 200070: a neuroprotective agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135418373
CHEMBL ID188528
SCHEMBL ID3930187
MeSH IDM0487016

Synonyms (30)

Synonym
7-bromo-2-(4-hydroxy-phenyl)-benzooxazol-5-ol
bdbm50154088
7-bromo-2-(4-hydroxyphenyl)benzo[d]oxazol-5-ol
CHEMBL188528 ,
5-benzoxazolol, 7-bromo-2-(4-hydroxyphenyl)-
7-bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol
7-bromo-2-(4-hydroxyphenyl)-5-benzoxazolol
way-200070
440122-66-7
4-(7-bromo-5-hydroxy-3h-1,3-benzoxazol-2-ylidene)cyclohexa-2,5-dien-1-one
way200070
way 200070
gtpl4052
BAAILVWEAXFTSF-UHFFFAOYSA-N
SCHEMBL3930187
way-00005
AKOS024457585
DTXSID80432027
way-200070, >=98% (hplc)
CS-6398
HY-101271
BCP28989
HMS3677L08
Q25100803
HMS3413L08
C75188
EX-A5522
7-bromanyl-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol
lk94jp5jt7 ,
A935041

Dosage Studied

ExcerptReference
" A dose-response paradigm was used, with each compound tested at 4 different doses in separate groups of rats."( Estrogen Receptor-Selective Agonists Modulate Learning in Female Rats in a Dose- and Task-Specific Manner.
Katzenellenbogen, JA; Korol, DL; Neese, SL; Pisani, SL; Schantz, SL, 2016
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Estrogen receptor betaMus musculus (house mouse)IC50 (µMol)0.00170.00176.636010.0000AID242354
Estrogen receptorHomo sapiens (human)IC50 (µMol)0.15500.00000.723732.7000AID242369
Estrogen receptorRattus norvegicus (Norway rat)IC50 (µMol)0.13200.00074.152114.1600AID242327
Estrogen receptorMus musculus (house mouse)IC50 (µMol)0.13200.03326.195210.0000AID242370
Estrogen receptor betaRattus norvegicus (Norway rat)IC50 (µMol)0.00120.00124.765214.1600AID242314
Estrogen receptor betaHomo sapiens (human)IC50 (µMol)0.00180.00010.529432.7000AID242353; AID382409
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (44)

Processvia Protein(s)Taxonomy
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
antral ovarian follicle growthEstrogen receptorHomo sapiens (human)
epithelial cell developmentEstrogen receptorHomo sapiens (human)
chromatin remodelingEstrogen receptorHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
signal transductionEstrogen receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayEstrogen receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationEstrogen receptorHomo sapiens (human)
androgen metabolic processEstrogen receptorHomo sapiens (human)
male gonad developmentEstrogen receptorHomo sapiens (human)
negative regulation of gene expressionEstrogen receptorHomo sapiens (human)
positive regulation of phospholipase C activityEstrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayEstrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptorHomo sapiens (human)
response to estradiolEstrogen receptorHomo sapiens (human)
regulation of toll-like receptor signaling pathwayEstrogen receptorHomo sapiens (human)
negative regulation of smooth muscle cell apoptotic processEstrogen receptorHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionEstrogen receptorHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
response to estrogenEstrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
fibroblast proliferationEstrogen receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEstrogen receptorHomo sapiens (human)
stem cell differentiationEstrogen receptorHomo sapiens (human)
regulation of inflammatory responseEstrogen receptorHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
RNA polymerase II preinitiation complex assemblyEstrogen receptorHomo sapiens (human)
uterus developmentEstrogen receptorHomo sapiens (human)
vagina developmentEstrogen receptorHomo sapiens (human)
prostate epithelial cord elongationEstrogen receptorHomo sapiens (human)
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisEstrogen receptorHomo sapiens (human)
regulation of branching involved in prostate gland morphogenesisEstrogen receptorHomo sapiens (human)
mammary gland branching involved in pregnancyEstrogen receptorHomo sapiens (human)
mammary gland alveolus developmentEstrogen receptorHomo sapiens (human)
epithelial cell proliferation involved in mammary gland duct elongationEstrogen receptorHomo sapiens (human)
protein localization to chromatinEstrogen receptorHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptorHomo sapiens (human)
negative regulation of miRNA transcriptionEstrogen receptorHomo sapiens (human)
regulation of epithelial cell apoptotic processEstrogen receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
signal transductionEstrogen receptor betaHomo sapiens (human)
cell-cell signalingEstrogen receptor betaHomo sapiens (human)
negative regulation of cell growthEstrogen receptor betaHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptor betaHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptor betaHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (29)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
TFIIB-class transcription factor bindingEstrogen receptorHomo sapiens (human)
transcription coregulator bindingEstrogen receptorHomo sapiens (human)
transcription corepressor bindingEstrogen receptorHomo sapiens (human)
transcription coactivator bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
chromatin bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
nuclear receptor activityEstrogen receptorHomo sapiens (human)
steroid bindingEstrogen receptorHomo sapiens (human)
protein bindingEstrogen receptorHomo sapiens (human)
calmodulin bindingEstrogen receptorHomo sapiens (human)
beta-catenin bindingEstrogen receptorHomo sapiens (human)
zinc ion bindingEstrogen receptorHomo sapiens (human)
TBP-class protein bindingEstrogen receptorHomo sapiens (human)
enzyme bindingEstrogen receptorHomo sapiens (human)
protein kinase bindingEstrogen receptorHomo sapiens (human)
nitric-oxide synthase regulator activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor bindingEstrogen receptorHomo sapiens (human)
estrogen response element bindingEstrogen receptorHomo sapiens (human)
identical protein bindingEstrogen receptorHomo sapiens (human)
ATPase bindingEstrogen receptorHomo sapiens (human)
14-3-3 protein bindingEstrogen receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingEstrogen receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptor betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptor betaHomo sapiens (human)
DNA bindingEstrogen receptor betaHomo sapiens (human)
nuclear steroid receptor activityEstrogen receptor betaHomo sapiens (human)
nuclear receptor activityEstrogen receptor betaHomo sapiens (human)
steroid bindingEstrogen receptor betaHomo sapiens (human)
protein bindingEstrogen receptor betaHomo sapiens (human)
zinc ion bindingEstrogen receptor betaHomo sapiens (human)
enzyme bindingEstrogen receptor betaHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptor betaHomo sapiens (human)
estrogen response element bindingEstrogen receptor betaHomo sapiens (human)
receptor antagonist activityEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
nucleusEstrogen receptorHomo sapiens (human)
nucleoplasmEstrogen receptorHomo sapiens (human)
transcription regulator complexEstrogen receptorHomo sapiens (human)
cytoplasmEstrogen receptorHomo sapiens (human)
Golgi apparatusEstrogen receptorHomo sapiens (human)
cytosolEstrogen receptorHomo sapiens (human)
plasma membraneEstrogen receptorHomo sapiens (human)
membraneEstrogen receptorHomo sapiens (human)
chromatinEstrogen receptorHomo sapiens (human)
euchromatinEstrogen receptorHomo sapiens (human)
protein-containing complexEstrogen receptorHomo sapiens (human)
nucleusEstrogen receptorHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
nucleoplasmEstrogen receptor betaHomo sapiens (human)
mitochondrionEstrogen receptor betaHomo sapiens (human)
intracellular membrane-bounded organelleEstrogen receptor betaHomo sapiens (human)
chromatinEstrogen receptor betaHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID382409Binding affinity to ERbeta2008European journal of medicinal chemistry, Jan, Volume: 43, Issue:1
Classification of estrogen receptor-beta ligands on the basis of their binding affinities using support vector machine and linear discriminant analysis.
AID249863Total bone mineral density in ovariectomized rat when treated with compound at 10 mg/kg dose2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID244177Selectivity fold for estrogen receptor beta over estrogen receptor alpha2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID249867Trabecular bone mineral density in ovariectomized rat when treated with combination of compound (10 mg/kg) and estradiol (2 ug/rat)2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID242314Inhibition of [3H]17-beta-estradiol binding to rat ER beta expressed in Escherichia coli2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID250791Effect of compound (15 mg/kg) on rat vasomotor instability in terms of tail skin temperature change 15 min after naloxone injection2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID249810Weight of rat uterine when treated with combination of compound and Ethynyl estradiol was determined2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID242369Inhibitory concentration against human ER alpha expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID242327Inhibition of [3H]17-beta-estradiol binding to rat ER alpha expressed in Escherichia coli2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID249794Weight of rat uterine when treated with compound at 2 mg dose was determined2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID242370Inhibition of [3H]17-beta-estradiol binding to mouse ER alpha expressed in Escherichia coli2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID1417087Selectivity index, ratio of IC50 for full-length human ERalpha to IC50 for full length rat ERbeta2018European journal of medicinal chemistry, Sep-05, Volume: 157Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs).
AID242353Inhibitory concentration against human ER beta expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID249799Weight of mouse uterine when treated with compound at 50 mg/kg dose was determined2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID242354Inhibition of [3H]17-beta-estradiol binding to mouse ER beta expressed in Escherichia coli2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID250952Effect of combination of compound and PPT on rat vasomotor instability in terms of tail skin temperature change 15 min after naloxone injection2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID249866Total bone mineral density in ovariectomized rat when treated with combination of compound (10 mg/kg) and estradiol (2 ug/rat)2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID249865Trabecular bone mineral density in ovariectomized rat when treated with compound at 10 mg/kg dose2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID1346880Human Estrogen receptor-beta (3A. Estrogen receptors)2008Neuropharmacology, Jun, Volume: 54, Issue:7
WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
AID1346880Human Estrogen receptor-beta (3A. Estrogen receptors)2004Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
AID1346845Human Estrogen receptor-alpha (3A. Estrogen receptors)2008Neuropharmacology, Jun, Volume: 54, Issue:7
WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (29.17)29.6817
2010's17 (70.83)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]